HireRight Holdings Corporation (HRT) Stock Competitors & Peer Comparison
See (HRT) competitors and their performances in Stock Market.
Peer Comparison Table: Staffing & Employment Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HRT | $14.36 | -0.14% | 967.2M | -130.55 | -$0.11 | N/A |
| ADP | $216.31 | -1.61% | 86.5B | 20.14 | $10.74 | +3.04% |
| PAYX | $96.72 | +0.44% | 34.7B | 17.55 | $5.51 | +4.56% |
| BZ | $12.65 | -3.73% | 5.8B | 11.19 | $1.13 | +1.31% |
| KFY | $70.57 | -1.60% | 3.7B | 13.27 | $5.32 | +2.81% |
| RHI | $30.09 | +0.03% | 3.1B | 23.15 | $1.30 | +7.75% |
| TNET | $47.25 | +0.08% | 2.2B | 9.09 | $5.20 | +2.37% |
| MAN | $33.81 | +3.74% | 1.6B | 11.12 | $3.04 | +4.26% |
| NSP | $38.41 | +0.79% | 1.5B | 49.88 | $0.77 | +6.25% |
| HSII | $59.01 | +0.00% | 1.2B | 34.31 | $1.72 | +0.51% |
Stock Comparison
HRT vs ADP Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, ADP has a market cap of 86.5B. Regarding current trading prices, HRT is priced at $14.36, while ADP trades at $216.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas ADP's P/E ratio is 20.14. In terms of profitability, HRT's ROE is -0.02%, compared to ADP's ROE of +0.69%. Regarding short-term risk, HRT is less volatile compared to ADP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check ADP's competition here
HRT vs PAYX Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, PAYX has a market cap of 34.7B. Regarding current trading prices, HRT is priced at $14.36, while PAYX trades at $96.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas PAYX's P/E ratio is 17.55. In terms of profitability, HRT's ROE is -0.02%, compared to PAYX's ROE of +0.45%. Regarding short-term risk, HRT is less volatile compared to PAYX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check PAYX's competition here
HRT vs BZ Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, BZ has a market cap of 5.8B. Regarding current trading prices, HRT is priced at $14.36, while BZ trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas BZ's P/E ratio is 11.19. In terms of profitability, HRT's ROE is -0.02%, compared to BZ's ROE of +0.18%. Regarding short-term risk, HRT is less volatile compared to BZ. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BZ's competition here
HRT vs KFY Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, KFY has a market cap of 3.7B. Regarding current trading prices, HRT is priced at $14.36, while KFY trades at $70.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas KFY's P/E ratio is 13.27. In terms of profitability, HRT's ROE is -0.02%, compared to KFY's ROE of +0.14%. Regarding short-term risk, HRT is less volatile compared to KFY. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KFY's competition here
HRT vs RHI Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, RHI has a market cap of 3.1B. Regarding current trading prices, HRT is priced at $14.36, while RHI trades at $30.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas RHI's P/E ratio is 23.15. In terms of profitability, HRT's ROE is -0.02%, compared to RHI's ROE of +0.10%. Regarding short-term risk, HRT is less volatile compared to RHI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RHI's competition here
HRT vs TNET Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, TNET has a market cap of 2.2B. Regarding current trading prices, HRT is priced at $14.36, while TNET trades at $47.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas TNET's P/E ratio is 9.09. In terms of profitability, HRT's ROE is -0.02%, compared to TNET's ROE of +1.80%. Regarding short-term risk, HRT is less volatile compared to TNET. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check TNET's competition here
HRT vs MAN Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, MAN has a market cap of 1.6B. Regarding current trading prices, HRT is priced at $14.36, while MAN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas MAN's P/E ratio is 11.12. In terms of profitability, HRT's ROE is -0.02%, compared to MAN's ROE of -0.01%. Regarding short-term risk, HRT is less volatile compared to MAN. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check MAN's competition here
HRT vs NSP Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, NSP has a market cap of 1.5B. Regarding current trading prices, HRT is priced at $14.36, while NSP trades at $38.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas NSP's P/E ratio is 49.88. In terms of profitability, HRT's ROE is -0.02%, compared to NSP's ROE of -0.32%. Regarding short-term risk, HRT is less volatile compared to NSP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check NSP's competition here
HRT vs HSII Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, HSII has a market cap of 1.2B. Regarding current trading prices, HRT is priced at $14.36, while HSII trades at $59.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas HSII's P/E ratio is 34.31. In terms of profitability, HRT's ROE is -0.02%, compared to HSII's ROE of +0.08%. Regarding short-term risk, HRT is more volatile compared to HSII. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check HSII's competition here
HRT vs UPWK Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, UPWK has a market cap of 970.9M. Regarding current trading prices, HRT is priced at $14.36, while UPWK trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas UPWK's P/E ratio is 8.54. In terms of profitability, HRT's ROE is -0.02%, compared to UPWK's ROE of +0.18%. Regarding short-term risk, HRT is less volatile compared to UPWK. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check UPWK's competition here
HRT vs KFRC Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, KFRC has a market cap of 837M. Regarding current trading prices, HRT is priced at $14.36, while KFRC trades at $47.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas KFRC's P/E ratio is 23.83. In terms of profitability, HRT's ROE is -0.02%, compared to KFRC's ROE of +0.27%. Regarding short-term risk, HRT is less volatile compared to KFRC. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KFRC's competition here
HRT vs BBSI Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, BBSI has a market cap of 835.3M. Regarding current trading prices, HRT is priced at $14.36, while BBSI trades at $34.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas BBSI's P/E ratio is 17.01. In terms of profitability, HRT's ROE is -0.02%, compared to BBSI's ROE of +0.18%. Regarding short-term risk, HRT is less volatile compared to BBSI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BBSI's competition here
HRT vs HHR Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, HHR has a market cap of 761.1M. Regarding current trading prices, HRT is priced at $14.36, while HHR trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas HHR's P/E ratio is 9.05. In terms of profitability, HRT's ROE is -0.02%, compared to HHR's ROE of +0.58%. Regarding short-term risk, HRT is less volatile compared to HHR. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HHR's competition here
HRT vs KELYB Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, KELYB has a market cap of 633.3M. Regarding current trading prices, HRT is priced at $14.36, while KELYB trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas KELYB's P/E ratio is 19.91. In terms of profitability, HRT's ROE is -0.02%, compared to KELYB's ROE of -0.25%. Regarding short-term risk, HRT is more volatile compared to KELYB. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check KELYB's competition here
HRT vs KELYA Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, KELYA has a market cap of 403.2M. Regarding current trading prices, HRT is priced at $14.36, while KELYA trades at $11.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas KELYA's P/E ratio is 12.78. In terms of profitability, HRT's ROE is -0.02%, compared to KELYA's ROE of -0.25%. Regarding short-term risk, HRT is less volatile compared to KELYA. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check KELYA's competition here
HRT vs ZIP Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, ZIP has a market cap of 341.2M. Regarding current trading prices, HRT is priced at $14.36, while ZIP trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas ZIP's P/E ratio is -14.12. In terms of profitability, HRT's ROE is -0.02%, compared to ZIP's ROE of +0.33%. Regarding short-term risk, HRT is less volatile compared to ZIP. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check ZIP's competition here
HRT vs TBI Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, TBI has a market cap of 198.7M. Regarding current trading prices, HRT is priced at $14.36, while TBI trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas TBI's P/E ratio is -9.34. In terms of profitability, HRT's ROE is -0.02%, compared to TBI's ROE of -0.19%. Regarding short-term risk, HRT is less volatile compared to TBI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check TBI's competition here
HRT vs HQI Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, HQI has a market cap of 174.5M. Regarding current trading prices, HRT is priced at $14.36, while HQI trades at $12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas HQI's P/E ratio is 17.63. In terms of profitability, HRT's ROE is -0.02%, compared to HQI's ROE of +0.10%. Regarding short-term risk, HRT is less volatile compared to HQI. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HQI's competition here
HRT vs DHX Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, DHX has a market cap of 153.7M. Regarding current trading prices, HRT is priced at $14.36, while DHX trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas DHX's P/E ratio is 11.12. In terms of profitability, HRT's ROE is -0.02%, compared to DHX's ROE of -0.02%. Regarding short-term risk, HRT is less volatile compared to DHX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check DHX's competition here
HRT vs MHH Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, MHH has a market cap of 92.3M. Regarding current trading prices, HRT is priced at $14.36, while MHH trades at $7.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas MHH's P/E ratio is 10.13. In terms of profitability, HRT's ROE is -0.02%, compared to MHH's ROE of +0.03%. Regarding short-term risk, HRT is less volatile compared to MHH. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check MHH's competition here
HRT vs BGSF Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, BGSF has a market cap of 60.9M. Regarding current trading prices, HRT is priced at $14.36, while BGSF trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas BGSF's P/E ratio is -5.92. In terms of profitability, HRT's ROE is -0.02%, compared to BGSF's ROE of -0.22%. Regarding short-term risk, HRT is less volatile compared to BGSF. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check BGSF's competition here
HRT vs NIXX Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, NIXX has a market cap of 31.9M. Regarding current trading prices, HRT is priced at $14.36, while NIXX trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas NIXX's P/E ratio is -3.63. In terms of profitability, HRT's ROE is -0.02%, compared to NIXX's ROE of -1.13%. Regarding short-term risk, HRT is less volatile compared to NIXX. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check NIXX's competition here
HRT vs HSON Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, HSON has a market cap of 25.5M. Regarding current trading prices, HRT is priced at $14.36, while HSON trades at $9.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas HSON's P/E ratio is -7.08. In terms of profitability, HRT's ROE is -0.02%, compared to HSON's ROE of -0.16%. Regarding short-term risk, HRT is less volatile compared to HSON. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check HSON's competition here
HRT vs JOB Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, JOB has a market cap of 22.6M. Regarding current trading prices, HRT is priced at $14.36, while JOB trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas JOB's P/E ratio is -13.59. In terms of profitability, HRT's ROE is -0.02%, compared to JOB's ROE of -0.02%. Regarding short-term risk, HRT is less volatile compared to JOB. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check JOB's competition here
HRT vs RCRT Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, RCRT has a market cap of 11M. Regarding current trading prices, HRT is priced at $14.36, while RCRT trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas RCRT's P/E ratio is -0.98. In terms of profitability, HRT's ROE is -0.02%, compared to RCRT's ROE of -1.13%. Regarding short-term risk, HRT is less volatile compared to RCRT. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RCRT's competition here
HRT vs PIXY Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, PIXY has a market cap of 3.3M. Regarding current trading prices, HRT is priced at $14.36, while PIXY trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas PIXY's P/E ratio is 0.01. In terms of profitability, HRT's ROE is -0.02%, compared to PIXY's ROE of +0.73%. Regarding short-term risk, HRT is less volatile compared to PIXY. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check PIXY's competition here
HRT vs GLXG Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, GLXG has a market cap of 2.6M. Regarding current trading prices, HRT is priced at $14.36, while GLXG trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas GLXG's P/E ratio is -0.08. In terms of profitability, HRT's ROE is -0.02%, compared to GLXG's ROE of -0.79%. Regarding short-term risk, HRT is less volatile compared to GLXG. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check GLXG's competition here
HRT vs IPDN Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, IPDN has a market cap of 1.3M. Regarding current trading prices, HRT is priced at $14.36, while IPDN trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas IPDN's P/E ratio is -0.35. In terms of profitability, HRT's ROE is -0.02%, compared to IPDN's ROE of -0.78%. Regarding short-term risk, HRT is less volatile compared to IPDN. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check IPDN's competition here
HRT vs CLIK Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, CLIK has a market cap of 998.9K. Regarding current trading prices, HRT is priced at $14.36, while CLIK trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas CLIK's P/E ratio is -0.03. In terms of profitability, HRT's ROE is -0.02%, compared to CLIK's ROE of +0.03%. Regarding short-term risk, HRT is less volatile compared to CLIK. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check CLIK's competition here
HRT vs EPWK Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, EPWK has a market cap of 360.9K. Regarding current trading prices, HRT is priced at $14.36, while EPWK trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas EPWK's P/E ratio is -0.24. In terms of profitability, HRT's ROE is -0.02%, compared to EPWK's ROE of +0.13%. Regarding short-term risk, HRT is more volatile compared to EPWK. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check EPWK's competition here
HRT vs NIXXW Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, NIXXW has a market cap of 348.6K. Regarding current trading prices, HRT is priced at $14.36, while NIXXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas NIXXW's P/E ratio is -0.04. In terms of profitability, HRT's ROE is -0.02%, compared to NIXXW's ROE of -1.13%. Regarding short-term risk, HRT is less volatile compared to NIXXW. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check NIXXW's competition here
HRT vs RCRTW Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, RCRTW has a market cap of 11.5K. Regarding current trading prices, HRT is priced at $14.36, while RCRTW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas RCRTW's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to RCRTW's ROE of -1.13%. Regarding short-term risk, HRT is less volatile compared to RCRTW. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check RCRTW's competition here
HRT vs STAF Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, STAF has a market cap of 164. Regarding current trading prices, HRT is priced at $14.36, while STAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas STAF's P/E ratio is -0.00. In terms of profitability, HRT's ROE is -0.02%, compared to STAF's ROE of -95.92%. Regarding short-term risk, HRT is less volatile compared to STAF. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check STAF's competition here
HRT vs SFN Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, SFN has a market cap of 0. Regarding current trading prices, HRT is priced at $14.36, while SFN trades at $25.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas SFN's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to SFN's ROE of +0.13%. Regarding short-term risk, HRT is less volatile compared to SFN. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check SFN's competition here
HRT vs JOBS Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, JOBS has a market cap of 0. Regarding current trading prices, HRT is priced at $14.36, while JOBS trades at $60.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas JOBS's P/E ratio is 42.20. In terms of profitability, HRT's ROE is -0.02%, compared to JOBS's ROE of +0.05%. Regarding short-term risk, HRT is more volatile compared to JOBS. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check JOBS's competition here
HRT vs CVG Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, CVG has a market cap of 0. Regarding current trading prices, HRT is priced at $14.36, while CVG trades at $83.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas CVG's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to CVG's ROE of +0.09%. Regarding short-term risk, HRT is more volatile compared to CVG. This indicates potentially higher risk in terms of short-term price fluctuations for HRT.Check CVG's competition here
HRT vs TRR Comparison June 2026
HRT plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRT stands at 967.2M. In comparison, TRR has a market cap of 0. Regarding current trading prices, HRT is priced at $14.36, while TRR trades at $17.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRT currently has a P/E ratio of -130.55, whereas TRR's P/E ratio is N/A. In terms of profitability, HRT's ROE is -0.02%, compared to TRR's ROE of +0.00%. Regarding short-term risk, HRT is less volatile compared to TRR. This indicates potentially lower risk in terms of short-term price fluctuations for HRT.Check TRR's competition here